Hospitals

Need Help or want to give your feedback?

Whether you’re having trouble with your account, or would like to make a suggestion, Canadian Blood Services offers you quick and convenient options to troubleshoot or get in touch. Contact us via live chat, consult our FAQ, send an email feedback@blood.ca, or give us a call at 1 888 2 DONATE (1-888-236-6283).

Customer Letters

Please note: The following Customer Letters, in electronic format, do not replace the version that you receive from your local Canadian Blood Services site. The version that you receive from your local Canadian Blood Services must be retained as your file copy.

* The contents of the customer letters available on this site are current as of their dates of publication. If required, please contact the Canadian Blood Services staff member identified within the letters or contact your local Hospital Liaison Specialist to determine if the letter is still current.


2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Contact Lists Referenced in Customer Letters Effective Date
Hospital Liaisons 2015-08-01

2018

Customer Letter 2018-03 (PDF) 2018-01-23 

INFORMATION ONLY
Release of Revised Circular of Information for Plasma Components

Customer Letter 2018-03 (PDF)

Customer Letter 2018-02 (PDF) 2018-01-22

INFORMATION ONLY
Notification of Change of Site for IgA Program

Customer Letter 2018-02 (PDF) | IgA anti-IgA Patient Request Form

Customer Letter 2018-01 (PDF) 2018-01-18

INFORMATION ONLY
Revisions to the Special Request Order Form

Customer Letter 2018-01 (PDF)

2017

Customer Letter 2017-48 (PDF) 2017-12-28

ACTION REQUIRED
Increase in Collection of ACD-A Apheresis Fresh Frozen Plasma and New ISBT Component Codes

Customer Letter 2017-48 (PDF)

Customer Letter 2017-47 (PDF) 2017-12-21

INFORMATION ONLY
2017 Holiday Message and Inventory Update

Customer Letter 2017-47 (PDF)

Customer Letter 2017-46 (PDF) 2017-12-15

INFORMATION ONLY
Plasma Protein Products Request for Proposal Results-Update

Customer Letter 2017-46 (PDF) | FAQ - Fractionation Services and Recombinant Plasma Protein Products Product Supply and Transitioning | Plasma Protein Products Transition December 2017 Newsletter

Customer Letter 2017-45 (PDF) 2017-12-11

INFORMATION ONLY
Important Information Regarding Panzyga Availability

Customer Letter 2017-45 (PDF)

Customer Letter 2017-44 (PDF) 2017-12-01

INFORMATION ONLY 
Updates to CSL Behring’s Products

Customer Letter 2017-44 (PDF) | Alburex 5 and Alburex 25 with Tamper Evident Packaging Hizentra (PDF) | Hizentra Introduction of Pre-filled Syringe (PFS) 1g and 2g (PDF) | Hizentra Pre-filled Syringe Specifications Sheet (PDF)

Customer Letter 2017-43 (PDF) 2017-11-06

INFORMATION ONLY
Plasma Protein Products Updates

Customer Letter 2017-43 (PDF) | Bayer Customer Letter - Re-Introduction of the 5 mL Syringe for all Potencies of Kovaltry | Octapharma Customer Letter - Panzyga is now approved for Guillain-Barré Syndrome (GBS)

Customer Letter 2017-42 (PDF) 2017-10-31

INFORMATION ONLY
Plasma Protein Products Request for Proposal Results

Customer Letter 2017-42 (PDF)

Customer Letter 2017-41 (PDF) 2017-10-19

INFORMATION ONLY
The Transfer of Diagnostic Services From Regina to Vancouver

Customer Letter 2017-41 (PDF)

Customer Letter 2017-40 (PDF) 2017-10-10

INFORMATION ONLY
Implementation of New Insulated Shipping Containers for Hospital Deliveries – Brampton

Customer Letter 2017-40 (PDF) | Insulated Shipping Containers Packing Configurations | Instructions for Returning Insulated Shipping Containers to Canadian Blood Services | Safety Data Sheets (SDSs) for Phase Change Materials | Ergonomic Information

Customer Letter 2017-39 (PDF) 2017-09-25

INFORMATION ONLY
Changes to Red Blood Cell Extended Antigen Printing on the End Label

Customer Letter 2017-39 (PDF) | Phenotype Information - Red Blood Cell Label and Tag

Customer Letter 2017-38 (PDF) 2017-09-18

ACTION REQUIRED
Changes to HLA/HPA Request for Platelets – Eastern Canada
Western and Eastern Canada – Electronically Fillable Forms Now Available

Customer Letter 2017-38 (PDF)

Customer Letter 2017-37 (PDF) 2017-09-11

INFORMATION ONLY
Receipt of Xyntha 500 IU Lot N20360

Customer Letter 2017-37 (PDF) | Pfizer -  Receipt of Xyntha 500 IU Lot N20360 Customer Letter

Customer Letter 2017-36 (PDF) 2017-09-06

ACTION REQUIRED
Further Information - Changes to the Provision of CMV Seronegative Blood Products

Customer Letter 2017-36 (PDF)

Customer Letter 2017-35 (PDF) 2017-09-05

INFORMATION ONLY
Change to Notification of Adverse Transfusion or TRALI Reactions to Canadian Blood Services

Customer Letter 2017-35 (PDF)

Customer Letter 2017-34 (PDF) 2017-08-16

ACTION REQUIRED
Diagnostic Services, Brampton – Sample Shipping

Customer Letter 2017-34 (PDF)

Customer Letter 2017-33 (PDF) 2017-08-01

INFORMATION ONLY
Implementation update: Release of Revised Circular of Information for Plasma Components Last updated July 2017 version

Customer Letter 2017-33 (PDF)

Customer Letter 2017-32 (PDF) 2017-07-31

ACTION REQUIRED
WinRho® SDF (1500 IU) Quarantine Cancellation

Customer Letter 2017-32 (PDF) |Aptevo Therapeutics Inc. Customer Letter  | Confirmation of discard form

Customer Letter 2017-31 (PDF) 2017-07-19

INFORMATION ONLY
Implementation Update; Extension of Platelet Components Shelf Life From 5 to 7 Days

Customer Letter 2017-31 (PDF)

Customer Letter 2017-30 (PDF) 2017-07-13

INFORMATION ONLY
Berinert® Approved for Pediatric Hereditary Angioedema (HAE)

Customer Letter 2017-30 (PDF) |  CSL Behring – Berinert Customer Letter

Customer Letter 2017-29 (PDF) 2017-07-11

INFORMATION ONLY
Important Information Regarding Changes to the Expiry Date of Irradiated Red Blood Cells

Customer Letter 2017-29 (PDF)

Customer Letter 2017-28 (PDF) 2017-07-10

INFORMATION ONLY
Grifols’ Plasbumin®-5(Albumin (Human) 5%, USP) – Low Aluminum – 50 mL format

Customer Letter 2017-28 (PDF) | Grifols - Plasbumin-5 (Low Aluminium) 50 mL Customer Letter

Customer Letter 2017-27 (PDF) 2017-07-06

INFORMATION ONLY
Production Announcement – Transfer of Regina Production Activities to Calgary

Customer Letter 2017-27 (PDF)

Customer Letter 2017-26 (PDF) 2017-06-29

INFORMATION ONLY
Release of Revised Circular of Information for Plasma Components Last updated July 2017 version

Customer Letter 2017-26 (PDF)

Customer Letter 2017-25 (PDF) 2017-06-26

ACTION REQUIRED
Changes to HLA/HPA Request for Platelets

Customer Letter 2017-25 (PDF) 

Customer Letter 2017-24 (PDF) 2017-06-22

INFORMATION ONLY
Implementation of New Insulated Shipping Containers for Hospital Deliveries – Ottawa

Customer Letter 2017-24 (PDF) | ISC Packing Configurations | Instructions for Returning ISCs to Canadian Blood Services | SDS for Phase Change Materials | Ergonomic Information

Customer Letter 2017-23 (PDF) 2017-06-19

INFORMATION ONLY
Diagnostic Services Laboratory, Edmonton Center
Revised Request for Serological Investigation Form (LL4800)
for Alberta and North West Territory hospitals

Customer Letter 2017-23 (PDF) | Request for Serological Investigation | Guidance document for completion of Request for Serological Investigation

Customer Letter 2017-22 (PDF) 2017-06-15

INFORMATION ONLY
Changes to Recommendations for the Provision of CMV Seronegative Blood Products

Customer Letter 2017-22 (PDF)

Customer Letter 2017-21 (PDF) 2017-06-01

ACTION REQUIRED
ISBT Component Codes for Extra Washed Red Blood Cells

Customer Letter 2017-21 (PDF) | Attachment 1 -Extra Washed Red Blood Cell Components

Customer Letter 2017-20 (PDF) 2017-05-29

INFORMATION ONLY
Changes to Deglycerolized (thawed) Red Blood Cells

Customer Letter 2017-20 (PDF) | Attachment 1 - Deglycerolized (thawed) Red Blood Cell Component Codes, Description and Label Sample

Customer Letter 2017-19 (PDF) 2017-05-18

INFORMATION ONLY
Update to the Discontinuation of Octagam®

Customer Letter 2017-19 (PDF)

Customer Letter 2017-18 (PDF) 2017-05-18

INFORMATION ONLY
Results of Hospital Practice Survey – Group AB Cryoprecipitate

Customer Letter 2017-18 (PDF)

Customer Letter 2017-17 (PDF) 2017-05-09

ACTION REQUIRED
Relocation of the Diagnostic Services Laboratory, Southern Central Ontario

Customer Letter 2017-17 (PDF)

Customer Letter 2017-16 (PDF) 2017-05-08

INFORMATION ONLY
Implementation of New Insulated Shipping Containers for Hospital Deliveries
Dartmouth, NS, Saint John, NB and St. John’s, NL

Customer Letter 2017-16 (PDF) | Attachment 1 - ISC Packing Configurations | Attachment 2 - Instructions for Returning ISCs to Canadian Blood Services | Attachment 3 - Safety Data Sheets (SDS) for Phase Change Materials | Attachment 4 - Ergonomic Information

Customer Letter 2017-15 (PDF) 2017-04-27

INFORMATION ONLY
New Dosing Optimization Program for Tretten®

Customer Letter 2017-15 (PDF) | Improved Dosing Reimbursement Program for Tretten®

Customer Letter 2017-14 (PDF) 2017-04-20 INFORMATION ONLY

Changes to group AB cryoprecipitate production

Customer Letter 2017-14 (PDF)

Customer Letter 2017-13 (PDF) 2017-04-13

INFORMATION ONLY
Implementation Update: Extension of Platelet Components Shelf Life From 5 to 7 Days

Customer Letter 2017-13 (PDF)

Customer Letter 2017-12 (PDF) 2017-04-06

INFORMATION ONLY
Release of Revised Circulars of Information for Plasma Components, Platelets and Red Blood Cells

Customer Letter 2017-12 (PDF)

Customer Letter 2017-11 (PDF) 2017-03-31

INFORMATION ONLY
Implementation Date for New Insulated Shipping Containers for Hospital Deliveries - Winnipeg Production and Distribution Site

Customer Letter 2017-11 (PDF)

Customer Letter 2017-10 (PDF) 2017-03-30

INFORMATION ONLY
Diagnostic Services Laboratory, Edmonton Center
Mailing/Faxing routine prenatal reports to Alberta Hospitals of Delivery

Customer Letter 2017-10 (PDF)

Customer Letter 2017-09 (PDF) 2017-03-30

INFORMATION ONLY
Discontinuation of Octagam®

Customer Letter 2017-09 (PDF)

Customer Letter 2017-08 (PDF) 2017-03-13

INFORMATION ONLY
Availability of Immune Globulin Products for 2017-2018

Customer Letter 2017-08 (PDF)

Customer Letter 2017-07 (PDF) 2017-02-17

INFORMATION ONLY
Information Regarding Thawing of Octaplasma™

Customer Letter 2017-07 (PDF) | Octaplasma® thawing instructions and information

Customer Letter 2017-06 (PDF) 2017-02-07

INFORMATION ONLY
Updates to Labeling of Products Manufactured by Cangene Corporation

Customer Letter 2017-06 (PDF) | Aptevo label transition letter

Customer Letter 2017-05 (PDF) 2017-02-06

ACTION REQUIRED
Important Information Regarding Changes to the Expiry Date of Irradiated Red Blood Cells

Customer Letter 2017-05 (PDF)

Customer Letter 2017-04 (PDF) 2017-01-30

ACTION REQUIRED
Diagnostic Services Laboratory, Toronto Centre – HLA Sample Shipping For Hospitals
in the Greater Toronto Area

Customer Letter 2017-04 (PDF)

Customer Letter 2017-03 (PDF) 2017-01-26

INFORMATION ONLY
Implementation of New Insulated Shipping Containers for Hospital Deliveries
British Columbia and Yukon, Edmonton, Calgary, Saskatchewan and Winnipeg

Customer Letter 2017-03 (PDF) | Attachment 1 - ISC Packing Configurations | Attachment 2 - Instructions for Returning ISCs to Canadian Blood Services | Attachment 3 - Safety Data Sheets (SDS) for Phase Change Materials | Attachment 4 - Ergonomic Information

Customer Letter 2017-02 (PDF) 2017-01-25

ACTION REQUIRED
Extension of Platelet Components Shelf Life from 5 to 7 Days

Customer Letter 2017-02 (PDF)

Customer letter 2017-01 (PDF) 2017-01-03

INFORMATION ONLY
Updates to Octapharma’s Products Distributed by Canadian Blood Services

Customer letter 2017-01 (PDF) | Introduction of Panzyga® | Octagam® label enhancement